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Repetitive progressive thermal preconditioning
hinders thrombosis by reinforcing
phosphatidylinositol 3-kinase/Akt-dependent
heat-shock protein/endothelial nitric oxide
synthase signaling
Ping-Chia Li, PhD,a Chih-Ching Yang, MD, PhD,b,c Shih-Ping Hsu, MD, PhD,d,e and
Chiang-Ting Chien, PhD,f,g Kaohsiung, Taipei, and New Taipei City, Taiwan
Objective: We compared the effects of modified progressive thermal preconditioning (PTP) and whole-body thermal
preconditioning (TP) on stress responses, oxidative stress biomarkers, and arterial thrombosis formation, and explored
their possible actions through phosphatidylinositol 3-kinase (PI3K)/Akt-dependent heat-shock protein (Hsp)/
endothelial nitric oxide synthase (eNOS) pathways.
Methods: We divided four groups of 249 male Wistar rats into nonimmersed controls, TP, and one (1-PTP) and three
consecutive cycles (3-PTP) of PTP in a 42°C water bath. We evaluated the stress responses, including hemodynamics,
total energy transfer, endoplasmic reticulum (ER) stress marker glucose-regulated protein (GRP78), and blood reactive
oxygen species level during TP or PTP treatment. We compared 1-PTP, 3-PTP, or TP effects on oxidative stress,
intercellular adhesion molecule 1 (ICAM-1), Hsp70, tissue plasminogen activator (t-PA) and plasminogen activator
inhibitor type 1 (PAI-1) activity, and vascular phosphorylated Akt (p-Akt) and eNOS (p-eNOS) expressions in a model
of topical ferric chloride (FeCl3)-induced carotid artery thrombosis.
Results:PTP significantly (P< .05) induced less hemodynamic fluctuations, total energy transfer, ER, andoxidative stress than
TP did. After 24 or 72 hours of treatment, 1-PTP, 3-PTP, and TP significantly (P < .05) elevated carotid arterial Hsp70,
p-Akt, and p-eNOS expression, significantly (P < .05) depressed FeCl3-enhanced vascular 2=,7=-dichlorodihydrofluorescein
diacetate, chemokine (C-X3-Cmotif) ligand 1 (CX3CL1), 3-nitrotyrosine, 4-hydroxynonenal, and ICAM-1 stain, PAI-1, and
t-PA activity, leukocyte infiltration and thrombus size, and significantly (P< .05) delayed thrombus formation comparedwith
controls. 3-PTP and TP had a higher (P< .05) protection than 1-PTP. PI3K/Akt, Hsp70, or N(G)-nitro-l-arginine methyl
ester hydrochloride (L-NAME) inhibitors significantly (P < .05) depressed 3-PTP and TP-induced vascular protection.
Conclusions: Repetitive PTP is better than single PTP to hinder thrombosis formation via reinforcing PI3K/Akt-
dependent Hsp70/eNOS signaling. (J Vasc Surg 2012;56:159-70.)
Clinical Relevance: This study implicates that a modified progressive thermal preconditioning (PTP) evokes less
endoplasmic reticulum and oxidative stress in blood vessels than whole-body thermal preconditioning (TP). TP and PTP
confer vascular protection via phosphatidylinositol 3-kinase (PI3K)/Akt-dependent heat-shock protein (Hsp)/endothelial
nitric oxide synthase (eNOS) signaling.However, the vascular protection of three consecutive cycles of PTP (3-PTP) treatment
is similar to TP but is more efficient than one PTP (1-PTP) cycle to hinder oxidative stress-induced thrombosis. 3-PTP
providesmore vascular protection than 1-PTPby inhibiting oxidative stress, chemokine, and adhesionmolecule production in
blood vessels through the reinforcement of PI3K/Akt-dependent Hsp/eNOS signaling. This study demonstrates that
repetitive PTP is a safe, effective, and available strategy to protect against oxidative stress-induced thrombosis by reinforcing
PI3K/Akt-dependent Hsp70/e-NOS signaling. We suggest that these preclinical data are sufficient to conduct a small, phase
I proof-of-concept study and we may validate the outcome variables, including plasma and urinary nitrite and nitrate, or
evaluate other physiologic parameters before and after surgery. PTP may be used as prophylaxis against vascular disease.
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July 2012160 Li et alExcess reactive oxygen species (ROS) oxidize several
macromolecules and promote atherosclerosis and throm-
bosis.1-3 Locally exaggerated vascular ROS decrease the
bioavailability of nitric oxide (NO), impair vascular relax-
ation, and increase leukocyte or platelet adhesion and ag-
gregation in injured vessels.3,4 ROS can increase fractalkine
chemokine (C-X3-C motif) ligand 1 (CX3CL1) and inter-
cellular adhesion molecule-1 (ICAM-1) expressions on in-
jured endothelium, attract fractalkine receptor (CX3CR1)-
expression inflammatory cells to the inflamed area,5 and
provoke atherosclerosis and vascular inflammation.6 In-
creased ROS may induce endoplasmic reticulum (ER)
stress to trigger cellular apoptosis7 and overexpress proapo-
ptotic p53 to trigger endothelial apoptosis and vascular
dysfunction.8 Increased ROS can also affect platelet re-
sponses9 and enhance platelet aggregation and adhesion to
impaired endothelium.10
Endogenous and exogenous antioxidants protect the
vascular endothelium by reducing thrombotic and athero-
sclerotic injury caused by ROS.11 Cardiovascular protec-
tion is achievable by hypoxic, ischemic, anesthetic, estrogen
receptor, or thermal preconditioning (TP).12-15 Among
these, TP is the most accessible in daily life. Increased
heat-shock protein (Hsp) expression, affording different
degrees of resistance and tolerance to oxidative injury,
depends on the magnitude and duration of heat stimula-
tion.16,17Whole-body TP (42°-43°C for 15-20minutes), a
widely used model, elicits Hsp expression and improves
cardiac recovery from subsequent ischemic or reperfusion
injury.18 However, whole-body TP is compromised by the
initial tissue injury and cardiovascular changes, limiting its
clinical applicability.19-21
Water-bath immersion at 41°C for 15 minutes in-
creases heart rate,20 and elevation of the core temperature
to 42°C for 15 minutes increases polymorphonuclear cell
migration to the myocardium.21 In some humans, hot
bathing TP induces acute myocardial and cerebral infarc-
tion 3 hours, possibly via transient changes in blood
pressure, heart rate, blood viscosity, fibrinolytic activity,
and platelet function.19 For prevention of exacerbated he-
modynamic variation during TP, a safe strategy for water-
bath immersion at 41°C is recommended to be5minutes
and that at 38°C is 10 minutes.20 However, the vascular
protection may be attenuated because of short duration
and low temperature (42°C). Considering safety and
efficiency, we have developed a modified method of pro-
gressive TP (PTP) with three steps of 42°C bathing to
attenuate the adverse effects, such as tachycardia or blood
pressure fluctuation, occurring in TP but still conferring
cardiovascular protection.13
Several preconditioning methods, including TP, re-
quire phosphatidylinositol 3-kinase (PI3K)/Akt signaling
for enhancing Hsp and endothelial nitric oxide synthase
(eNOS) expressions, phosphorylation of eNOS (p-eNOS)
at Ser-1177, and NO production to afford cardiovascular
protection.15,16,22,23 Repeated hypoxic preconditioning
significantly and efficiently protects tissues and organs
against subsequent injury compared with single hypoxic dreconditioning in decreasing oxidative and ER stress, au-
ophagy, apoptosis, and leukocyte infiltration.7 Repeated
auna or repeated thermal therapy has also been reported to
fficiently improve vascular endothelial dysfunction and
eointimal thickening.24,25
Our goal in this study was to determine whether mod-
fied PTP evokes more stable hemodynamics and less ER
nd oxidative stress in blood vessels than TP, to explore
hether PTP or TP induces vascular protection via PI3K/
kt-dependent Hsp/eNOS signaling, and to evaluate
hether increased PTP frequency more efficiently than
ingle PTP hinders oxidative stress-induced thrombosis.
he safely modified TP method is of protective potential
n reducing oxidative vascular injury in future clinical
rials.
ETHODS
Animals. The study used 249 male Wistar rats (200-
50 g), which were housed in the Experimental Animal
enter, National Taiwan University. All the surgical and
xperimental procedures were approved by the Institu-
ional Animal Care and Use Committee of the National
aiwan University College of Medicine and College of
ublic Health and were in accordance with the guidelines
f the National Science Council of Republic of China (NSC
997).
Setup for TP and PTP. The models for whole-body
P and PTP were designed (Fig 1), and the grouping,
umber, and procedural details of the experimental groups
re described in the Table. As shown in Fig 1, A, the
nimals in group TP were directly immersed into the 42°C
ater bath at line 3 for 15 minutes, whereas those in group
TP were progressively immersed into the 42°C water bath
rom line 1 to line 3 for a respective 5-minute period. The
otal amount of heat energy transfer to the animal was
alculated as the area under curve of the time vs colonic
emperature relationship. We performed five studies as
escribed in the Table.
Measurement of hemodynamic parameters. The
easurement of arterial blood pressure and heart rate was
escribed previously.13
Ferric chloride-induced acute arterial thrombosis.
he rat model of topical ferric chloride (FeCl3)-induced
arotid artery or femoral artery thrombosis (peripheral ar-
ery occlusive diseases) has been used extensively to assess
he antithrombotic activities of test agents.4,8 To easily
onitor blood flow and obtain larger tissue sampling, we
elected a carotid artery thrombosis model. We placed a
ow probe (Probe 0.5VBB517, Transonic Systems, Inc,
thaca, NY) in the left carotid artery for measurement of
rterial blood flow in the anesthetized rats. The right
arotid artery, without injury, was used as the control.
The artery was wrapped with a filter paper (1 mm  2
m) soaked with 30% FeCl3 solution (Sigma, St. Louis,
o) or saline.4 The adventitial FeCl3 solution easily diffused
nto the arterial tissue, induced a Fenton reaction-mediated
njury (impairment of NO release), and subsequently re-
uced arterial blood flow within minutes. Periadvential
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Volume 56, Number 1 Li et al 161FeCl3 treatment would affect endothelium, media, and
intima in the carotid artery. The flow rate was continuously
recorded, and the required time to induce complete arterial
occlusion (arterial blood flow decreases to 0) was defined as
time to occlusion (TTO).
We considered that TP or PTP might affect the degree
and process of oxidative stress, inflammatory leukocytes, and
thrombus size in the carotid arteries.We selected 900 seconds
of FeCl3 stimulation to the carotid artery to determine the
degree of oxidative stress (2=,7=-dichlorodihydrofluorescein
diacetate [DCFDA], CX3CL1, 3-nitrotyrosine [3-NT],
4-hydroxynonenal [4-HNE], and ICAM-1), inflammatory
leukocytes, and thrombus size before its complete occlu-
sion. Tissue sections were prepared from Tissue-Tek opti-
mal cutting temperature (OCT) compound (Sakura Finetek,
Torrance, Calif) or fixed in 10% formalin. The control and
injured arterial sections were stained by hematoxylin and
eosin (H&E) to measure the thrombus size and number of
infiltrated leukocytes (blue nuclei stain by H&E stain). The
thrombus size was determined by Photoshop 7.0.1 imag-
ing software (Adobe, San Jose, Calif) using the formula: %
thrombus size  thrombus area of intravascular area/total
Fig 1. A, The setup for thermal preconditioning (TP) o
rat is demonstrated. The bath water was maintained at
performed progressively at line 1 for 5 minutes, line 2
temperature (CT) change is recorded in control (Con), P
(AUC; mean timeCT) of three groups are displayed. A
in TP and PTP groups compared with the Con group. T
error bars show the standard error of the mean. D, TP
increased final mean blood pressure (MBP). F, TP and
group. *P  .05 vs Con; #P  .05 vs TP with saline treaintravascular area  100. tImmunocytochemistry. High levels of ROS induced
y FeCl3 might increase the expressions of CX3CL1 and
CAM-1 and the accumulation of protein and lipid perox-
des in the endothelium. We used 5 mol/L DCFDA
Sigma-Aldrich) to evaluate vascular oxidative stress after
he FeCl3-induced injury
26 and 1 mol/L propidium io-
ide (PI; Sigma-Aldrich) to determine cellular DNA dam-
ge in each section. The fluorescence intensity in the arte-
ial sections was evaluated by fluorescence microscopy
model DMRD; Leica Microsystems, Wetzlar, Germany).
Paraffin-embedded sections of carotid arterial rings
rom eight groups of rats (n  6/group) subjected to 900
econds of FeCl3 stimulation were evaluated for vascular
OS levels and were immunostained to examine CX3CL1,
-NT, 4-HNE, and ICAM-1 expressions.4 The percentage
f staining in the vascular rings was calculated by the
ormula: % staining  stained curved length/total curved
ength.
Blood ROS assay. We measured blood ROS levels as
escribed previously.2
Vascular malondialdehyde measurement. The vas-
ular malondialdehyde (MDA) level, an indicator of oxida-
ressive thermal preconditioning (PTP) in the conscious
. TP was performed at line 3 for 15 minutes. PTP was
5 minutes, and line 3 for 5 minutes. B, The colonic
and TP groups. C, The respective areas under the curve
ficant (P .05) increase in total energy transfer is found
a higher total energy transfer than the PTP group. The
ases heart rate but PTP does not. E, TP but not PTP
ignificantly increased final CT when compared to Con
t.r prog
42°C
for
TP,
signi
P has
incre
PTP sive stress, was measured as described previously.1
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July 2012162 Li et alTissue plasminogen activator and plasminogen
activator-1 activity assay. Increased plasminogen activa-
tor inhibitor type 1 (PAI-1) and tissue plasminogen activa-
tor (t-PA) concentrations promote thrombosis.27 We deter-
mined the effects of TP and PTP on functionally active t-PA
(PAI-free) and PAI-1 (PA-free) in the carotid arteries by
using the active rat t-PA enzyme-linked immunosorbent
assay (ELISA) kit and the active rat PAI-1 ELISA kit
(Molecular Innovations, Novi, Mich), according to the
manufacturer’s instructions.
Immunoblotting. In some rats (n 6/group), intra-
peritoneal PI3K/Akt inhibitors wortmannin (10 nmol/
min/kg) and LY294002 (2-(4-morpholinyl)-8-phenyl-
1(4H)-benzopyran-4-one hydrochloride; 1 mol/min/
kg; Sigma-Aldrich), Hsp70 inhibitor quercetin (100 mg/
kg; Sigma-Aldrich), and L-NAME (N(G)-nitro-l-arginine
methyl ester hydrochloride), an NO synthase inhibitor (15
mg/kg; Sigma-Aldrich), were administered 2 hours before
each PTP or TP experiment.10,20 Immunoblotting was
Table. Experimental grouping, number, and conditions
Grouping No.
Part 1 Stress response (heart rate, blood pressure
Control 12 Control rats with nonimmersion treatmen
TP 24 Thermal preconditioning (fast immersion
phentolamine, propranolol, atropine (n
PTP 24 Progressive thermal preconditioning (slow
phentolamine, propranolol, atropine (n
Part 2 Stress response (GRP78, Hsp70, p-Akt, p
Control 3 Control rats with nonimmersion treatmen
TP 12 After TP of 0.5, 1, 2, and 4 hours (n  3
1-PTP 12 After one cycle of PTP of 0.5, 1, 2, and 4
3-PTP 12 After three consecutive cycles of PTP of 0
Part 3 TTO response and signaling
Con 8 Control rats with nonimmersion treatmen
TP-24 6 Thermal preconditioning (fast immersion
hours
TP-72 6 Thermal preconditioning (fast immersion
1-PTP-24 8 One cycle of progressive thermal precond
TTO after 24 hours
1-PTP-72 8 One cycle of progressive thermal precond
TTO after 72 hours
3-PTP-24 8 Three consecutive cycles of progressive th
over 6 hours, followed by TTO after 24
3-PTP-72 8 Three consecutive cycles of progressive th
over 6 hours, followed by TTO after 72
Part 4 Oxidative stress, CX3CL1, ICAM-1, thro
Control 12 Control rats with nonimmersion treatmen
TP-24 6 TP-24, followed by 900 seconds FeCl3 tre
TP-72 6 TP-72, followed by 900 seconds FeCl3 tre
1-PTP-24 6 1-PTP-24, followed by 900 seconds FeCl
1-PTP-72 6 1-PTP-72, followed by 900 seconds FeCl
3-PTP-24 6 3-PTP-24, followed by 900 seconds FeCl
3-PTP-72 6 3-PTP-72 followed by 900 seconds FeCl3
Part 5 Inhibitors on Hsp70, p-Akt, p-eNOS, car
Control 5 Controls with nonimmersion treatment
TP-72 20 TP-72 without treatment, LY294002, qu
(n  5 each)
3-PTP-72 25 3-PTP-72 without treatment, wortmannin
CX3CL1, Chemokine (C-X3-C motif) ligand 1; GRP78, glucose-regulat
molecule 1; L-NAME, N(G)-nitro-l-arginine methyl ester hydrochloride
synthase; TTO, time to total occlusion.performed as described previously.10-12 iStatistical analysis. All values are expressed as the
ean  standard error of the mean (SEM). Differences
ithin groups were evaluated by a paired t-test. One-way
nalysis of variance was used to establish differences among
roups. Intergroup comparisons were made by Duncan’s
ultiple-range test. Differences were regarded as signifi-
ant for P  .05.
ESULTS
PTP showed a less stress response than TP. TP and
TP increased the colonic temperature to 41° or 40°C,
espectively, after 15 minutes of water immersion (Fig 1, B
nd F). Total energy transfer measured by the area under
urve was significantly higher in the TP than in the PTP
roup (Fig 1,C). PTP did not enhance heart rate (Fig 1,D)
r mean blood pressure (Fig 1, E), but TP significantly
ncreased both hemodynamic parameters. Intraperitoneal
ropranolol significantly (P  .05) suppressed the TP-
nhanced heart rate, phentolamine significantly (P  .05)
Condition
drug treatment)
°C water for 15 minutes) with pretreatment of saline,
each)
ersion to 42°C water for 15 minutes) with pretreatment of saline
each)
S)
s (n  3 each)
2, and 4 hours (n  3 each)
°C water for 15 minutes), followed by carotid TTO after 24
°C water for 15 minutes), followed by TTO after 72 hours
ng (slow immersion to 42°C water for 15 minutes), followed by
ng (slow immersion to 42°C water for 15 minutes), followed by
preconditioning (slow immersion to 42°C water for 15 minutes)
rs
preconditioning (slow immersion to 42°C water for 15 minutes)
rs
size, leukocyte infiltration
h or without 900 seconds FeCl3 treatment (n  6 each)
nt
nt
tment
tment
tment
ment
rterial TTO
n, L-NAME
294002, quercetin, L-NAME (n  5 each)
tein 78; Hsp70, heat-shock protein 70; ICAM-1, intercellular adhesion
t, phosphorylated-Akt; p-eNOS, phosphorylated endothelial nitric oxide, and
t
to 42
 6
imm
 6
-eNO
t
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hour
.5, 1,
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Volume 56, Number 1 Li et al 163did not affect either parameter induced by TP. Propranolol,
phentolamine, and atropine did not affect heart rate and
mean blood pressure in the PTP group. Leukocyte infiltra-
tion into myocardium from control, TP, and 1-PTP groups
(n  3 each) was 3.6  0.5, 7.9  1.1, and 4.2  0.5
counts/400 section. TP treatment had a significantly
(P .05) higher leukocyte infiltration than the control and
1-PTP groups.
The temporal responses (0.5-4 hours) of the carotid
arterial p-eNOS, p-Akt, glucose-regulated protein
(GRP78), and Hsp70 expressions after TP, 1-PTP, and
3-PTP treatment are demonstrated in Fig 2, A. Enhanced
p-eNOS expression was recognized after 2 hours of 1-PTP
treatment, 0.5 hour of 3-PTP, and 0.5 hour of TP treat-
ment. Enhanced p-Akt was found after 1 hour of 1-PTP, 1
hour of 3-PTP, and 0.5 hour of TP stimulation. Increased
GRP78 expression was identified after 2 hours of 1-PTP, 1
hour of 3-PTP, and 0.5 hour of TP treatment. Elevated
Hsp70 expression was noted after 2 hours of 1-PTP, 0.5
hour of 3-PTP, and 0.5 hour of TP. Expressions of p-eNOS
and p-Akt were similar between 3-PTP and TP after 4 hours
of treatment, whereas GRP78 and Hsp70 expressions were
highly expressed in the TP group compared with the 3-PTP
or 1-PTP groups. The expression of p-eNOS, p-Akt,
GRP78, and Hsp70 was mildly enhanced in the 1-PTP
group but was highly enhanced in the 3-PTP and TP groups.
After 0.5 to 4 hours of 1-PTP, 3-PTP, or TP treatment,
blood ROS levels were significantly increased vs the control
group (Fig 2, B). However, the increased ROS levels were
significantly (P .05) less in the 1-PTP and 3-PTP groups
than in the TP group.
Vascular protection after 1-PTP, 3-PTP, and TP.
The responses of carotid arterial blood flow to FeCl3 stim-
ulation in seven groups of animals are demonstrated in Fig
3, A. FeCl3 stimulation significantly reduced carotid arte-
rial blood flow in all groups between 1250 and 2600
seconds (Fig 3, A). The time for reducing carotid arterial
blood flow to zero (carotid TTO) was significantly (P 
.05) extended in the 1-PTP, 3-PTP, and TP groups vs the
control group. The TTO values in the 3-PTP-24 and
3-PTP-72 groups were not significantly different from
those in TP-24 and TP-72 groups (see the Table for a
description of the experimental groups). TTO levels in
1-PTP-24 and 1-PTP-72 were significantly less than those
in 3-PTP or TP groups (Fig 3, B).
PTP and TP decreased FeCl3-induced vascular ox-
idative stress and CX3CL1 expression. In response to
900 seconds of FeCl3 stimulation, we evaluated the degree
of oxidative stress, CX3CL1, thrombus size, and infiltrated
leukocytes in FeCl3-induced vascular injury by analyzing
vascular oxidative stress (DCFDA, green fluorescence),
cellular DNA damage (PI, red fluorescence; Fig 4, A-D),
CX3CL1 expression (brown color; Fig 4, E-H), thrombus
size (Fig 4, I-L), and leukocyte number (arrows in Fig 4,
M-P) by H&E stain in the carotid arteries of seven groups.
Representative histologic sections of the carotid arteries
illustrate the calculation of thrombus size (thrombus area
blue area  black area) and the number of inflammatory iells (blue nuclei indicated by arrows). There were no
arked stains of DCFDA (Fig 4, A) and CX3CL1 (Fig 4,
), no thrombus formation (Fig 4, I), and almost rare
eukocyte stain (Fig 4, M) in the control artery without
eCl3 injury. However, a marked stain in DCFDA (Fig 4,
) and CX3CL1 (Fig 4, F), thrombus formation (Fig 4, J),
nd increased leukocyte number (Fig 4, N) were noted in
ontrol arteries with FeCl3 injury. 3-PTP-72 or TP-72
reatment decreased FeCl3-induced DCFDA (Fig 4, C and
) and CX3CL1 (Fig 4,G andH), thrombus size (Fig 4,K
nd L), and leukocyte number (Fig 4, O and P) in these
rterial sections. Analysis showed that FeCl3-increased
hrombus size was significantly suppressed in 1-PTP,
-PTP, and TP groups (Fig 4, Q), whereas increased leu-
ocyte number in thrombus was depressed by 1-PTP,
-PTP, and TP treatment (Fig 4, R). 3-PTP was more
ignificantly (P  .05) efficient than 1-PTP in reducing
hrombus size and leukocyte infiltration. 3-PTP had a
imilar effect vs TP treatment.
PTP and TP on FeCl3-induced vascular ICAM-1,
-NT, and 4-HNE. In response to 900 seconds of FeCl3
timulation, we determined the vascular ICAM-1, 3-NT,
nd 4-HNE expressions of the carotid arteries in control,
-PTP-72, 3-PTP-72, and TP-72 groups (Fig 5, A). En-
anced vascular ICAM-1 (Fig 5, Ab-e), 4-HNE (Fig 5,
g-j), and 3-NT (Fig 5,Al-o) expressions were observed in
he FeCl3-treated carotid arteries compared with nonin-
ured arteries (Fig 5, Aa, Af, and Ak). These enhanced
xpressions were significantly (P  .05) suppressed in the
-PTP-72, 3-PTP-72, and TP-72 groups compared with
he control group (Fig 5, B). Further, 3-PTP-72 and TP-72
ere significantly (P  .05) more efficient than 1-PTP-72
o reduce oxidative stress stains. There was no difference in
hese stains between 3-PTP-72 and TP-72 groups.
The arterial MDA concentration after the FeCl3-induced
njury was significantly (P  .05) increased in controls,
-PTP-72, 3-PTP-72, and TP-72 groups compared with
on–FeCl3-treated groups. However, the elevated MDA was
ignificantly depressed in 1-PTP-72, 3-PTP-72, and TP-72
roups (Fig 5,C). 3-PTP-72 andTP-72weremore (P .05)
fficient than 1-PTP-72 in reducing the MDA level.
The baseline level of vascular PAI-1 (Fig 5, D) and t-PA
Fig 5, E) activity was similar in controls, 1-PTP-72, 3-PTP-
2, and TP-72 groups. FeCl3 treatment significantly (P 
05) increased carotid arterial PAI-1 and t-PA activity. The
levated PAI-1 and t-PA activity was significantly (P  .05)
epressed in the 1-PTP-72, 3-PTP-72, and TP-72 groups.
PTP and TP enhanced carotid Hsp70, p-Akt, and
-eNOS expressions, and vascular protection. Hsp70,
-Akt, and p-eNOS expressions were all significantly (P 
05) increased in the carotid arteries of 1-PTP-24, 1-PTP-
2, 3-PTP-24, 3-PTP-72, TP-24, and TP-72 groups than
hose in the control group (Fig 6, A and B). The expres-
ions of these three proteins were most enhanced in the
-PTP-72 and TP-72 groups than in the other TP or PTP
roups. There was no significant difference between the
-PTP-72 and TP-72 groups. A significantly (P  .05)
ncreased NO amount in the carotid arterial samples was
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July 2012164 Li et alfound in all PTP or TP groups vs the control group (Fig 6,
C). The elevated NO response was very similar to the
pattern of p-eNOS expression. We further compared phar-
macologic inhibitors on Hsp70, p-Akt, and p-eNOS ex-
pression and carotid arterial TTO level in 3-PTP-72 and
TP-72 groups. Administration of intraperitoneal LY294002,
quercetin, and L-NAME significantly (P .05) suppressed
the enhanced Hsp70, p-Akt, and p-eNOS expressions be-
tween the 3-PTP-72 and TP-72 groups (Fig 6, D and E).
We also found that intraperitoneal LY294002, quercetin,
and L-NAME significantly reduced carotid TTO level to a
similar level between the 3-PTP-72 and TP-72 groups (Fig
6, F). These data implicate a similar signaling pathway and
Fig 2. A, The temporal responses (0.5-4 hours) of the c
oxide synthase (p-eNOS), p-Akt, glucose-regulated pro
1-PTP, and 3-PTP treatment are demonstrated. Enhance
treatment, 0.5 hour of 3-PTP, and 0.5 hour of TP treatm
of 3-PTP, and 0.5 hour of TP stimulation. Increased GR
of 3-PTP, and 0.5 hour of TP treatment. Elevated Hsp7
3-PTP, and 0.5 hour of TP. Expressions of p-eNOS and
treatment, whereas GRP78 and Hsp70 expressions were
1-PTP groups. The expression in p-eNOS, p-Akt, GRP78
highly enhanced in the 3-PTP and TP groups.B,After 0.5
oxygen species (ROS) levels were significantly increase
significantly less in the 1-PTP and 3-PTP groups compar
Progressive thermal preconditioning; 1-PTP, one cycle ovascular protection between 3-PTP and TP. cISCUSSION
Increased oxidative stress in the endothelium contrib-
tes to atherosclerosis and thrombosis. 1-PTP and 3-PTP
nduced less activation of -adrenoceptor-mediated hyper-
ension and 	-adrenoceptor-mediated tachycardia and less
nhancement of vascular ER stress and blood ROS levels
han TP did. 1-PTP, 3-PTP, and TP all induced vascular
rotection through PI3K/Akt–Hsp/eNOS-dependent
ignaling to hinder thrombus formation. However, 3-PTP
nd TP produce stronger vascular protection than 1-PTP
gainst FeCl3-induced thrombosis by inhibiting oxidative
tress, chemokine, and adhesion molecule expression in
arterial expression of phosphorylated endothelial nitric
(GRP78), and heat-shock protein (Hsp) 70 after TP,
NOS expression was recognized after 2 hours of 1-PTP
nhanced p-Akt was found after 1 hour of 1-PTP, 1 hour
xpression was identified after 2 hours of 1-PTP, 1 hour
pression was noted after 2 hours of 1-PTP, 0.5 hour of
kt were similar between 3-PTP and TP after 4 hours of
ly expressed in the TP group compared with 3-PTP or
Hsp70wasmildly enhanced in the 1-PTP group but was
hours of 1-PTP, 3-PTP, or TP treatment, blood reactive
control (Con) group. The increased ROS levels were
th the TP group. *P .05 vs respective TP group. PTP,
; 3-PTP, three cycles of PTP.arotid
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Volume 56, Number 1 Li et al 165TP at 42°C for 15 to 20 minutes enhances Hsp70
expression and improves cardiac function from subsequent
ischemic or reperfusion injury.18 TP-induced Hsp70 (co-
lonic temperatures from 41° to 42°C for 15minutes) is also
associated with a significant reduction in intimal accumu-
lation.28 A previous study stated that raising the core tem-
perature by 1°C for 15minutes once daily for five successive
Fig 3. A, The responses of carotid arterial blood flow to ferric
chloride (FeCl3) stimulation in seven groups of animals are dem-
onstrated. FeCl3 stimulation significantly reduced carotid arterial
blood flow in all groups between 1250 and 2600 seconds. The
time for reducing carotid arterial blood flow to zero (time to
occlusion [TTO]) was significantly extended in 1-PTP-24 (b),
1-PTP-72 (c), 3-PTP-24 (f), 3-PTP-72 (g), TP-24 (d) and TP-72
(e) groups vs control (Con) group (a). B, The TTO values in
3-PTP-24 and 3-PTP-72 were not significantly different than
those in TP-24 and TP-72 groups. TTO levels in 1-PTP-24 and
1-PTP-72 were significantly less than those in 3-PTP or TP
groups. *P  .05 vs Con without any treatment; #P  .05 vs
1-PTP-24. The error bars show the standard error of the mean.
PTP, Progressive thermal preconditioning; TP, thermal precondi-
tioning; see the Table for explanation of 1-PTP-24, 1-PTP-72,
3-PTP-24, 3-PTP-72, TP-24, and TP-72 experimental groups.days in TP can attenuate lung myeloperoxidase level, bron- whoalveolar lavage protein concentration, and tissue edema
y increased expression of Hsp72.17 However, these ben-
ficial effects are sometimes associated with adverse effects,
ncluding initial hemodynamic fluctuation, increased leu-
ocyte infiltration to the myocardium, and tissue injury,
hich may limit the clinical applicability of TP.20,21
TP at 40°C for more than 10 minutes evokes remark-
ble changes in sympathetic but not vagal-mediated heart
ate and blood pressure.13 Overwhelming heat stress by
hole-body TP may exacerbate ER and oxidative stress,
oth possibly contributing to endothelial dysfunction. Our
ata showed ER stress GRP78 and blood ROS levels are
ignificantly elevated 0.5 hour after TP treatment, which
as earlier and more elevated than in the 1-PTP or 3-PTP
roups. Our data indicated significantly (P .05) increased
eukocyte infiltration into rat myocardium was also ob-
erved immediately after TP treatment compared with the
ontrol or PTP groups. Local application of heat to the
essel wall can be accomplished via specialized angioplasty
atheters, but the temperatures (50°-60°C) and timing (at
he time of angioplasty) used make it unlikely to convey a
rotective effect.29 Therefore, prevention of cardiovascular
ystem activation by enhanced sympathetic activity during
P is critically important.
TP at 39° to 40°Cmildly upregulatesHsp expression to
rovide thermotolerance and oxidative resistance without
etectable adverse effects; however, the degree of cardio-
ascular protection is less than that conferred by 42°C TP.
ild TP for 30 minutes at 42°C before hypoxia/reoxygen-
tion injury is a stimulus for Hsp72 protein expression,
hich reduces apoptosis formation in the human internal
ammary artery in vitro.30 An acceleration of thrombosis
n arterioles and venules subjected to local stress heating
42.5°C) for 30 minutes was probably due to upregulation
f the prothrombotic von Willebrand factor, despite anti-
hrombotic heme oxygenase-1, thrombomodulin, and
hrombospondin-1 induction.31
The present data, consistent with our previous re-
ort,13 indicate PTP attenuates enhanced hemodynamic
arameters via decreased activation of -adrenergic and
-adrenergic neurotransmission. The less enhanced levels
f ER stress and blood ROS were also noted during PTP
ompared with TP. These attenuated stress responses by
-PTP, however, are associated with similar Hsp70/e-
OS–dependent vascular protection to that achieved by
P. We also implicated 3-PTP is more efficient than 1-PTP
o reinforce PI3K/Akt-Hsp70/eNOS–mediated vascular
rotection.
Inflammatory cytokines activate vascular endothelial
ells to upregulate CX3CL1 and increase platelet adhesion
o collagen.32 Exposure of smooth muscle cells to high
lucose concentrations also results in increased CX3CL1
nd monocyte chemotactic protein-1 expression.33 In-
reased CX3CL1 expression induces ROS production in
ultured aortic endothelium6 and enhances endothelial
CAM-1 expression, leading to the subsequent accumula-
ion of activated leukocytes and platelets at the vascular
all.34 In our rat model, treatment with FeCl3 induced
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July 2012166 Li et alFig 4. The degree of oxidative stress chemokine (C-X3-C motif) ligand 1 (CX3CL1), thrombus size, and infiltrated
leukocytes in FeCl3-induced vascular injury is analyzed in response to 900 seconds of ferric chloride (FeCl3) stimulation
in the experimental groups.A-D,Vascular oxidative stress (2=,7=-dichlorodihydrofluorescein diacetate [DCFDA] green
fluorescence), cellular DNA damage (propidium iodide [PI], red fluorescence), (E-H)CX3CL1 expression (brown color),
(I-L) thrombus size, and (M-P) leukocyte number (arrows) by hematoxylin and eosin stain in the carotid arteries of
seven groups. A, There were no marked stain of DCFDA and (E) CX3CL1, (I) no thrombus formation, and (M)
almost rare leukocyte stain in control (Con) artery without FeCl3 injury. A marked stain in (B) DCFDA and (F)
CX3CL1, (J) thrombus formation, and (N) increased leukocyte number are found in Con artery with FeCl3 injury.
3-PTP-72 or TP-72 treatment decreased FeCl3-induced (C and D) DCFDA and (G and H) CX3CL1, (K and L)
thrombus size, and (O and P) leukocyte number in these arterial sections. Data analysis showed that FeCl3-increased
thrombus size was significantly suppressed in (Q) 1-PTP, 3-PTP, or TP groups, whereas increased leukocyte number
in thrombus was depressed by (R) 1-PTP, 3-PTP, and TP treatment. 3-PTPwasmore significantly efficient than 1-PTP
in reducing thrombus size and leukocyte infiltration. 3-PTP has a similar effect vs TP treatment. *P  .05 vs Con
without any treatment; #P  .05 vs Con with FeCl3;
aP  .05 vs 1-PTP group. PTP, Progressive thermal
preconditioning; TP, thermal preconditioning; see the Table for explanation of 3-PTP-72 and TP-72 experimental
groups.
JOURNAL OF VASCULAR SURGERY
Volume 56, Number 1 Li et al 167Fig 5. A, Vascular intercellular adhesion molecule 1 (ICAM-1), 3-nitrotyrosine (3-NT), and 4-hydroxynonenal
(4-HNE) expressions of the carotid arteries in control (Con), 1-PTP-72, 3-PTP-72, and TP-72 are shown in response
to 900 seconds of ferric chloride (FeCl3) stimulation. Enhanced vascular ICAM-1 (b-e), 4-HNE (g-j), and 3-NT (l-o)
expressions were found in FeCl3-treated carotid arteries compared with noninjured arteries (a, f, and k). B, These
enhanced expressions were significantly suppressed in the 1-PTP-72, 3-PTP-72, and TP-72 groups compared with the
Con group. There was no difference in these stains between 3-PTP-72 and TP-72 groups. The arterial malondialde-
hyde (MDA) concentration after the FeCl3-induced injury was significantly increased in the Con, 1-PTP-72,
3-PTP-72, and TP-72 groups compared with non–FeCl3-treated groups. C, The elevated MDA was significantly
depressed in 1-PTP-72, 3-PTP-72, and the TP-72 groups. 3-PTP-72 and TP-72 were more efficient than 1-PTP-72 in
reducing MDA level. D, The baseline level of vascular plasminogen activator inhibitor type 1 (PAI-1) and (E) tissue
plasminogen (t-PA) activity was similar in Con, 1-PTP-72, 3-PTP-72, and TP-72 groups. FeCl3 treatment significantly
increased carotid arterial PAI-1 and t-PA activity. The elevated PAI-1 and t-PA activity was significantly depressed in the
1-PTP-72, 3-PTP-72, and TP-72 groups. *P .05 vs Con without any treatment; #P .05 vs Con with FeCl3;
aP
.05 vs 1-PTP. PTP, Progressive thermal preconditioning; TP, thermal preconditioning; see the Table for explanation of
the 1-PTP-72, 3-PTP-72, and TP-72 groups.
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July 2012168 Li et althrombosis in the carotid artery, which is characterized by
enhanced endothelial disruption, extensive platelet and red
blood cell aggregation, increased CX3CL1 and ICAM-1
expressions, and increased inflammatory cell infiltration
along with increased ROS production in the endothelium,
smooth muscle cells, and adhered leukocytes and platelets.
The morphologic changes in the FeCl3-induced thrombus
is similar to those in coronary arterial thrombi in patients
with acute myocardial ischemia.32 Decreased antioxidant
Fig 6. A, Immunoblots demonstrate original heat-sho
phorylated endothelial nitric oxide synthase (p-eNOS). B
enhanced in the carotid arteries of 1-PTP-24, 1-PTP-7
those in the control (Con) group. C, A significantly incre
all PTP or TP groups vs the Con group. D and E, A
N(G)-nitro-l-arginine methyl ester hydrochloride (L-N
and p-eNOS expressions between the 3-PTP-72 andTP-72
also significantly reduced the carotid time to total occlusio
groups. *P .05 vs Con without any treatment; #P .05 v
1-PTP-72. See the Table for an explanation of the 1-PTP-2defense mechanisms promote thrombosis.35 sIn contrast, increased antioxidant defense mechanisms
revent or attenuate arteriolar and venular thrombosis by
uppressing monocyte or macrophage adhesion to endo-
helial cells and inhibiting endothelial CX3CL1 expression
nd H2O2-induced platelet or leukocyte aggregation.
35,36
P upregulates endogenous Hsp70 expression in the en-
othelium and arterial media and provides vascular protec-
ion.28 The present study has demonstrated that vascular
rotection can be achieved by 1-PTP, 3-PTP, or TP to
otein (Hsp)70, phosphorylated Akt (p-Akt), and phos-
p70, p-Akt, and p-eNOS expressions were significantly
TP-24, 3-PTP-72, TP-24, and TP-72 groups than in
NO amount in the carotid arterial samples was found in
istration of intraperitoneal LY294002, quercetin, and
) significantly suppressed the enhanced Hsp70, p-Akt,
ps.F, Intraperitoneal LY294002, quercetin, and L-NAME
O) level to a similar level between 3-PTP-72 and TP-72
ective 1-PTP-24, 3-PTP-24, or TP-24 group; aP .05 vs
PTP-72, TP-24, and TP-72 groups.ck pr
, Hs
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lium, thrombus size, and to attenuate the reduction in
carotid arterial blood flow. 3-PTP had a similar effect like
TP and was more efficient than 1-PTP to hinder thrombus
formation. Increased PAI-1 and t-PA concentrations en-
hance thrombosis27 and are found in FeCl3-treated carotid
arteries. However, TP, 1-PTP, or 3-PTP significantly de-
pressed FeCl3-enhanced PAI-1 and t-PA activity.
We determined the molecular mechanisms by which TP
and PTP conferred vascular protection in this study. Accord-
ing to our data and previous reports, diverse stress precondi-
tioning stimuli enhance Hsp70,7,13,22 eNOS, p-Akt at Ser-
473, and p-eNOS at Ser-1177 expressions15 through the
PI3K/Akt signaling pathway to increase NO production and
protection.23 TP treatment significantly attenuated infiltra-
tion of ED-1–positive inflammatory cells in adventitia of ves-
sels and suppressed neointimal thickening in cuff-injured ar-
teries with the enhancement of Hsp72 expression and
suppression of oxidative stress (nicotinamide adenine dinucle-
otide phosphate hydrogen [NADPH] oxidase, p22-phox,
and monocyte chemotactic protein-1 expression).25
TP pretreatment increased accumulation of Hsp70 and
Hsp32 and reduced tumor necrosis factor-–inducedupregu-
lation of ICAM-1 and vascular cell adhesion molecule-1
(VCAM-1).37 TP combined with Hsp70 inducer further
inhibits VCAM-1 and ICAM-1 expression compared with
TP alone.37 Heat stimulation of endothelial cells at 42°C
can enhance Hsp90/eNOS interactions, produce higher
NO, and depress oxidative stress.38 Our data in TP or
3-PTP displays a similar Hsp70/eNOS expression, vascular
protection against FeCl3 injury, oxidative stress, CX3CL1,
ICAM-1 and t-PA and PAI-1 activity. We suggest that all
these implications could evidence that PTP, like TP via
action of Hsp/eNOS, affects oxidative stress, inflamma-
tion, and adhesion molecule expression.
In addition, our data are consistent with previous re-
ports that NO release by endothelial cells correlates with
enhanced eNOS phosphorylation and LY294002, an in-
hibitor of the upstream activator of protein kinase B, PI3K,
inhibits eNOS phosphorylation and NO production.23
Luo et al27 demonstrated that transfection of active Akt
into rat femoral arteries increases NO production and rest-
ing blood vessel diameter and blood flow, implicating Akt
as the key regulator of vasomotor tone in vivo.
The present study demonstrated that PTP and TP both
enhanced Hsp70, p-Akt, and p-eNOS expressions in the
carotid artery and provided vascular protection by reducing
vascular ROS, CX3CL1, ICAM-1, 3-NT, and 4-HNE
expressions and leukocyte infiltration, leading to the inhi-
bition of thrombus formation. Most important, the rein-
forcement in PI3K/Akt-mediated protection by 3-PTP has
a similar protection found in TP. Furthermore, 3-PTP has
less stress responses in heart rate and blood pressure fluc-
tuations, elevated ER stress, and blood ROS levels as found
in TP. Wortmannin, LY294002, quercetin, and L-NAME
significantly abolish 3-PTP-induced or TP-induced protec-
tion of FeCl -induced vascular injury by the reduction of3
Hsp70, p-Akt, and p-eNOS expression. We also found thatlocking PI3K/Akt-Hsp70/eNOS signaling in 3-PTP or
P by pharmacologic inhibitors led to an acceleration of
hrombus formation. These results highlight the protective
ignaling cascade of PI3K/Akt–Hsp70/eNOS in mediat-
ng vascular protection induced by 3-PTP or TP.
ONCLUSIONS
In future clinical relevance, wemay use Jacuzzi hot tubs
or PTP treatment in patients before surgery. We suggest
hat these preclinical data are sufficient to conduct a small,
hase I proof-of-concept study, and we may validate the
utcome variables, including plasma and urinary nitrite and
itrate, or evaluate other physiologic parameters before and
fter surgery. PTP may be used as prophylaxis against
ascular disease. However, further experiments are needed
efore its clinical application.
Repetitive PTP is better than single PTP to provide an
ffective and available strategy to protect against oxidative
tress-induced thrombosis by reinforcing PI3K/Akt-
ependent Hsp70/eNOS signaling.
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